Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference
May 07 2024 - 7:30AM
Business Wire
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company
committed to advancing new medicines for patients with cancer,
today announced that its management team will participate in a
fireside chat at the 2024 RBC Capital Markets Global Healthcare
Conference in New York on Tuesday, May 14, 2024 at 3:35 pm EDT.
A live webcast of the fireside chat can be accessed under events
on the Verastem Oncology’s website at www.verastem.com. A replay of
the webcast will be archived on the website for approximately 90
days following the presentation.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a late-stage development
biopharmaceutical company committed to the development and
commercialization of new medicines to improve the lives of patients
diagnosed with cancer. Our pipeline is focused on RAS/MAPK-driven
cancers, specifically novel small molecule drugs that inhibit
critical signaling pathways in cancer that promote cancer cell
survival and tumor growth, including RAF/MEK inhibition and FAK
inhibition. For more information, please visit www.verastem.com and
follow us on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240507625461/en/
For Investor and Media Inquiries: Julissa Viana Vice
President, Corporate Communications and Investor Relations
investors@verastem.com or media@verastem.com
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Apr 2024 to May 2024
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From May 2023 to May 2024